Mobile App for Covid-19 Self-tests Developed by Greek University

May 04, 2021 | 2 minutes read

A covid-19 infection detection application has been developed by a team of Greek scientists from the Agricultural University of Athens. After the success of its recent clinical trials, the team of scientists is planning to publish the data collected.

App tests for Covid-19

The mobile app can be downloaded on smartphones to successfully detect Covid-19 infections immediately after they have occurred throughout clinical trials.

This would prove to be a huge achievement for the researchers that have been working to discover methods that can limit the spread of the virus. Allowing people to monitor their activities and avoid spreading the virus unknowingly when they are asymptomatic.

A biosensor  has been created by the team that detects the virus quickly with around 97.8% accuracy rate.

Once the application is released for public use, it would come with a sampling kit for people to test themselves at homes. The kit would include a special swab which would allow people to take samples from either their mouth or nose. The kit would also contain a solution for the swab to be inserted into.

Moreover, it would also accompany a small device – like the one used to monitor blood sugar – that would be connected to the patient’s phone to generate the results of the test.

It has been stated that the app provides a much easier, quicker, and simpler way for patients to test themselves, as compared to the traditional testing methods.

In future people would be able to self-test themselves at homes

According to Spyros Kintzios, director of Cell Technology Laboratory of the Department of Biotechnology at the university, “the results of clinical trials show that the method is very reliable and in the near future will enable citizens to do test themselves at home even with saliva samples.

“Our university, in collaboration with distinguished Greek scientists, is a pioneer in the creation of extremely advanced cellular biosensors, not only for common viruses such as influenza but also for many other dangerous infectious diseases.”